Ramanathan Yegappan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ramanathan Yegappan has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Rangasamy Jayakumar
School of Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi 682041, India
4 shared publications Vignesh Selvaprithiviraj
Centre for Nanosciences and Molecular Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, 682041, India
4 shared publications- Alan Edward Rowan
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Australia
3 shared publications - Jan Lauko
Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD 4072, Australia
3 shared publications - Nasim Amiralian
The University of Queensland
3 shared publications - Amanda W. Kijas
UQ Centre for Clinical Research, The University of Queensland, Herston, Australia
2 shared publications
Latest Publications
- Open Access
- 15 January 2026
- Published by MDPI AG in Nanomaterials
- Vol. 16 (2) , 112
Nanocellulose Coatings for Surgical Face Masks
Polypropylene (PP) nonwovens are widely used as filtration layers in surgical face masks, but their hydrophobic, inert surfaces limit their ability to attach functional coatings that adjust pore size and improve mechanical filtration. Herein, we exploit cellulose derived from sugarcane debris to construct nanocellulose coatings that modify the surface properties of PP mask nonwovens without altering the underlying fibre architecture. Cellulose pulp was fibrillated to cellulose nanofibres (CNFs) and functionalised to yield TEMPO-oxidised nanofibres (TCNFs) and cationic nanofibres (CCNFs). All these nanofibres retain a cellulose I structure with a thermal stability of well above an 80–100 °C drying window. The three nanocelluloses exhibit distinct combinations of surface charge and wettability (ζ ≈ −9, −73, and +76 mV), with various hydrophobicity. Dip coating produces nanocellulose coating layers on PP, with uniform coverage at 1 wt% for TCNF and CCNF. CCNF inverts the negative surface charge of PP and maintains the positive charge at 86% relative humidity. Ethanol pretreatment of PP increases CCNF coating adhesion and preserves a continuous nanoporous CCNF film on the PP surface under humid conditions. Cytotoxicity assays indicate no detectable cytotoxicity for coated or uncoated nonwovens. This work establishes sugarcane-derived nanocellulose, particularly CCNF and TCNF, as a potential biocompatible surface coating for PP mask nonwovens.
- 15 January 2026
- Published by MDPI AG in Nanomaterials
- Vol. 16 (2) , 112
Open AccessNanocellulose Coatings for Surgical Face Masks
Polypropylene (PP) nonwovens are widely used as filtration layers in surgical face masks, but their hydrophobic, inert surfaces limit their ability to attach functional coatings that adjust pore size and improve mechanical filtration. Herein, we exploit cellulose derived from sugarcane debris to construct nanocellulose coatings that modify the surface properties of PP mask nonwovens without altering the underlying fibre architecture. Cellulose pulp was fibrillated to cellulose nanofibres (CNFs) and functionalised to yield TEMPO-oxidised nanofibres (TCNFs) and cationic nanofibres (CCNFs). All these nanofibres retain a cellulose I structure with a thermal stability of well above an 80–100 °C drying window. The three nanocelluloses exhibit distinct combinations of surface charge and wettability (ζ ≈ −9, −73, and +76 mV), with various hydrophobicity. Dip coating produces nanocellulose coating layers on PP, with uniform coverage at 1 wt% for TCNF and CCNF. CCNF inverts the negative surface charge of PP and maintains the positive charge at 86% relative humidity. Ethanol pretreatment of PP increases CCNF coating adhesion and preserves a continuous nanoporous CCNF film on the PP surface under humid conditions. Cytotoxicity assays indicate no detectable cytotoxicity for coated or uncoated nonwovens. This work establishes sugarcane-derived nanocellulose, particularly CCNF and TCNF, as a potential biocompatible surface coating for PP mask nonwovens.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
Nanocellulose-directed ultrasmall copper nanoparticles for durable antimicrobial interfaces
Nanocellulose directs the formation and immobilisation of ultrasmall copper nanoparticles on PP nonwovens, creating a porous, durable coating with rapid broad-spectrum antibacterial and antiviral activity, including at high humidity.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
Nanocellulose-directed ultrasmall copper nanoparticles for durable antimicrobial interfaces
Nanocellulose directs the formation and immobilisation of ultrasmall copper nanoparticles on PP nonwovens, creating a porous, durable coating with rapid broad-spectrum antibacterial and antiviral activity, including at high humidity.
- Open Access
The Potential of Sugarcane Waste-Derived Cellulose Fibres as Haemostatic Agents
Haemorrhage control during surgery and following traumatic injury remains a critical, life-saving challenge. Cellulose products are already employed in commercially available haemostatic dressings. This work explores sourcing cellulose from sugarcane trash pulp to produce micro- and nanosized fibres with hydroxyl, carboxylic acid, and trimethylamine functional groups, resulting in either positive or negative surface charges. This paper assesses the influence of these fibres on multiple blood clotting parameters in both dispersed solutions and dry gauze applications. In vitro blood clotting studies demonstrated the significant haemostatic potential of cellulose fibres derived from sugarcane waste to initiate clotting. Plasma absorbance assays showed that the 0.25 mg/mL cellulose microfibre dispersion had the highest clotting performance. It was observed that no single property of surface charge, functionality, or fibre morphology exclusively controlled the clotting initiation measured. Instead, a combination of these factors affected clot formation, with negatively charged cellulose microfibres comprising hydroxyl surface groups providing the most promising result, accelerating the coagulation cascade mechanism by 67% compared to the endogenous activity. This difference in clot initiation shows the potential for the non-wood agricultural waste source of cellulose in haemostatic wound healing applications, contributing to the broader understanding of cellulose-based materials’ versatility and their applications in biomedicine.
Open AccessThe Potential of Sugarcane Waste-Derived Cellulose Fibres as Haemostatic Agents
Haemorrhage control during surgery and following traumatic injury remains a critical, life-saving challenge. Cellulose products are already employed in commercially available haemostatic dressings. This work explores sourcing cellulose from sugarcane trash pulp to produce micro- and nanosized fibres with hydroxyl, carboxylic acid, and trimethylamine functional groups, resulting in either positive or negative surface charges. This paper assesses the influence of these fibres on multiple blood clotting parameters in both dispersed solutions and dry gauze applications. In vitro blood clotting studies demonstrated the significant haemostatic potential of cellulose fibres derived from sugarcane waste to initiate clotting. Plasma absorbance assays showed that the 0.25 mg/mL cellulose microfibre dispersion had the highest clotting performance. It was observed that no single property of surface charge, functionality, or fibre morphology exclusively controlled the clotting initiation measured. Instead, a combination of these factors affected clot formation, with negatively charged cellulose microfibres comprising hydroxyl surface groups providing the most promising result, accelerating the coagulation cascade mechanism by 67% compared to the endogenous activity. This difference in clot initiation shows the potential for the non-wood agricultural waste source of cellulose in haemostatic wound healing applications, contributing to the broader understanding of cellulose-based materials’ versatility and their applications in biomedicine.
- 12 September 2023
- Published by University of Queensland Library
Understanding the science and application of snake venom proteins in wound management
The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.
- 12 September 2023
- Published by University of Queensland Library
Understanding the science and application of snake venom proteins in wound management
The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.
- Open Access
- 23 February 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Snake venom-defined fibrin architecture dictates fibroblast survival and differentiation
Fibrin is the provisional matrix formed after injury, setting the trajectory for the subsequent stages of wound healing. It is commonly used as a wound sealant and a natural hydrogel for three-dimensional (3D) biophysical studies. However, the traditional thrombin-driven fibrin systems are poorly controlled. Therefore, the precise roles of fibrin’s biophysical properties on fibroblast functions, which underlie healing outcomes, are unknown. Here, we establish a snake venom-controlled fibrin system with precisely and independently tuned architectural and mechanical properties. Employing this defined system, we show that fibrin architecture influences fibroblast survival, spreading phenotype, and differentiation. A fine fibrin architecture is a key prerequisite for fibroblast differentiation, while a coarse architecture induces cell loss and disengages fibroblast’s sensitivity towards TGF-β1. Our results demonstrate that snake venom-controlled fibrin can precisely control fibroblast differentiation. Applying these biophysical principles to fibrin sealants has translational significance in regenerative medicine and tissue engineering.
- 23 February 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Open AccessSnake venom-defined fibrin architecture dictates fibroblast survival and differentiation
Fibrin is the provisional matrix formed after injury, setting the trajectory for the subsequent stages of wound healing. It is commonly used as a wound sealant and a natural hydrogel for three-dimensional (3D) biophysical studies. However, the traditional thrombin-driven fibrin systems are poorly controlled. Therefore, the precise roles of fibrin’s biophysical properties on fibroblast functions, which underlie healing outcomes, are unknown. Here, we establish a snake venom-controlled fibrin system with precisely and independently tuned architectural and mechanical properties. Employing this defined system, we show that fibrin architecture influences fibroblast survival, spreading phenotype, and differentiation. A fine fibrin architecture is a key prerequisite for fibroblast differentiation, while a coarse architecture induces cell loss and disengages fibroblast’s sensitivity towards TGF-β1. Our results demonstrate that snake venom-controlled fibrin can precisely control fibroblast differentiation. Applying these biophysical principles to fibrin sealants has translational significance in regenerative medicine and tissue engineering.
- Open Access
- 9 June 2022
- Published by Wiley in Advanced Healthcare Materials
- Vol. 11 (15) , e2200574
Snake Venom Hydrogels as a Rapid Hemostatic Agent for Uncontrolled Bleeding
Uncontrolled bleeding from traumatic injury remains the leading cause of preventable death with loss of balance between blood clotting (coagulation) and blood clot breakdown (fibrinolysis). A major limitation of existing hemostatic agents is that they require a functioning clotting system to control the bleeding and are largely based on gauze delivery scaffolds. Herein, a novel rapid wound sealant, composed of two recombinant snake venom proteins, the procoagulant ecarin, to rapidly initiate blood clotting and the antifibrinolytic textilinin, to prevent blood clot breakdown within a synthetic thermoresponsive hydrogel scaffold is developed. In vitro, it is demonstrated that clotting is rapidly initiated with only nanomolar concentrations of venom protein and clot breakdown is effectively inhibited by textilinin. A stable clot is formed within 60 s compared to normal clot formation in 8 min. In vivo studies reveal that the snake venom hydrogel rapidly controls warfarin‐induced bleeding, reducing the bleed volume from 48% to 12% and has demonstrated immune compatibility. A new class of hemostatic agents that achieve formation of rapid and stable blood clots even in the presence of blood thinners is demonstrated here.
- 9 June 2022
- Published by Wiley in Advanced Healthcare Materials
- Vol. 11 (15) , e2200574
Open AccessSnake Venom Hydrogels as a Rapid Hemostatic Agent for Uncontrolled Bleeding
Uncontrolled bleeding from traumatic injury remains the leading cause of preventable death with loss of balance between blood clotting (coagulation) and blood clot breakdown (fibrinolysis). A major limitation of existing hemostatic agents is that they require a functioning clotting system to control the bleeding and are largely based on gauze delivery scaffolds. Herein, a novel rapid wound sealant, composed of two recombinant snake venom proteins, the procoagulant ecarin, to rapidly initiate blood clotting and the antifibrinolytic textilinin, to prevent blood clot breakdown within a synthetic thermoresponsive hydrogel scaffold is developed. In vitro, it is demonstrated that clotting is rapidly initiated with only nanomolar concentrations of venom protein and clot breakdown is effectively inhibited by textilinin. A stable clot is formed within 60 s compared to normal clot formation in 8 min. In vivo studies reveal that the snake venom hydrogel rapidly controls warfarin‐induced bleeding, reducing the bleed volume from 48% to 12% and has demonstrated immune compatibility. A new class of hemostatic agents that achieve formation of rapid and stable blood clots even in the presence of blood thinners is demonstrated here.
- 1 May 2019
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 177, 41-49
Nano polydopamine crosslinked thiol-functionalized hyaluronic acid hydrogel for angiogenic drug delivery
- 1 May 2019
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 177, 41-49
Nano polydopamine crosslinked thiol-functionalized hyaluronic acid hydrogel for angiogenic drug delivery
- 1 February 2019
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 122, 320-328
Injectable angiogenic and osteogenic carrageenan nanocomposite hydrogel for bone tissue engineering
- 1 February 2019
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 122, 320-328
Injectable angiogenic and osteogenic carrageenan nanocomposite hydrogel for bone tissue engineering
- 13 December 2018
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 2 (1) , 378-387
Antistaphylococcal and Neutrophil Chemotactic Injectable κ-Carrageenan Hydrogel for Infectious Wound Healing
Staphylococcus aureus wound infection is a major concern due to their resistance to topical antibiotics and their capacity to inhibit neutrophil migration at the infection site. To overcome these problems, we have developed 0.01% (v/v) octenedine dihydrochloride (Oct) and 0.5% (w/w) chitosan treated serum (CTS) containing 1.5% (w/v) κ-carrageenan hydrogel (κC). Oct is an antiseptic agent against which no resistance is reported so far and CTS has neutrophilic attractant properties. The prepared Oct-CTS-kC hydrogel is injectable and biocompatible. Using in vitro experiments, we demonstrated CTS can induce migration of polymorphonuclear neutrophils (PMN) and fibroblasts that can facilitate tissue regeneration at wounded site. In vitro release studies revealed sustained release of Oct and serum proteins from Oct-CTS-kC hydrogel. Antibacterial properties of developed hydrogels were tested against S. aureus and its clinical isolates. Further, the in vivo antibacterial efficacy of the prepared hydrogel was evaluated in S. aureus infected Sprague Dawley (SD) rat wound. Both in vitro and in vivo studies showed that Oct-CTS-kC hydrogel inhibited S. aureus growth. Thus, the developed Oct-CTS-kC hydrogel can be potentially exploited for S. aureus infected wound healing.
- 13 December 2018
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 2 (1) , 378-387
Antistaphylococcal and Neutrophil Chemotactic Injectable κ-Carrageenan Hydrogel for Infectious Wound Healing
Staphylococcus aureus wound infection is a major concern due to their resistance to topical antibiotics and their capacity to inhibit neutrophil migration at the infection site. To overcome these problems, we have developed 0.01% (v/v) octenedine dihydrochloride (Oct) and 0.5% (w/w) chitosan treated serum (CTS) containing 1.5% (w/v) κ-carrageenan hydrogel (κC). Oct is an antiseptic agent against which no resistance is reported so far and CTS has neutrophilic attractant properties. The prepared Oct-CTS-kC hydrogel is injectable and biocompatible. Using in vitro experiments, we demonstrated CTS can induce migration of polymorphonuclear neutrophils (PMN) and fibroblasts that can facilitate tissue regeneration at wounded site. In vitro release studies revealed sustained release of Oct and serum proteins from Oct-CTS-kC hydrogel. Antibacterial properties of developed hydrogels were tested against S. aureus and its clinical isolates. Further, the in vivo antibacterial efficacy of the prepared hydrogel was evaluated in S. aureus infected Sprague Dawley (SD) rat wound. Both in vitro and in vivo studies showed that Oct-CTS-kC hydrogel inhibited S. aureus growth. Thus, the developed Oct-CTS-kC hydrogel can be potentially exploited for S. aureus infected wound healing.
- Top Cited Papers
- 1 October 2018
- Published by Elsevier in Carbohydrate Polymers
- Vol. 198, 385-400
Carrageenan based hydrogels for drug delivery, tissue engineering and wound healing
- 1 October 2018
- Published by Elsevier in Carbohydrate Polymers
- Vol. 198, 385-400
Top Cited PapersCarrageenan based hydrogels for drug delivery, tissue engineering and wound healing